RNS Number : 2383I
Schiehallion Fund Limited (The)
03 August 2023
 

The Schiehallion Fund Limited

(the "Company")

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

C Share Conversion Timetable

Further to the announcement on 27 July 2023 that the Managers expect the C Share proceeds raised in 2021 to be more than 85% deployed following completion of an investment, the Board is pleased to announce that the C Share proceeds are now 86.6% deployed. Accordingly, set out below is the timetable for Conversion of the C Shares into New Ordinary Shares in accordance with the terms set out in the Company's prospectus dated 23 March 2021 (the "Prospectus").

 

 

Expected Timetable

 

Conversion Calculation Date

 

31 August 2023

Announcement of Conversion Ratio

8 September 2023

 

Conversion and C Share register closes

 

6:00 p.m. on 8 September 2023

Admission of New Ordinary Shares, with dealings commencing

 

8:00 a.m. on 11 September 2023

 

Crediting of CREST accounts with New Ordinary Shares

 

11 September 2023

 

Share Certificates in respect of New Ordinary Shares despatched

w/c 18 September 2023

 

 

 

 

Capitalised terms used but not defined in this announcement will have the same meaning as set out in the Prospectus.

 

 

 

 

Baillie Gifford & Co Limited

3rd August 2023

 

 

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws and regulations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBXLFBXVLLBBK